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Abstract

Alzheimer's disease (AD) and heart failure (HF) are two complex diseases that are caused by
the combination of genetic and epigenetic, environmental and other lifestyle factors.
Understanding the relationships between genetic and epigenetic variants and other factors of
such complex diseases could assist researchers discover disease mechanisms and develop
targeted therapies.

Much of the research in genetics/epigenetics studies regarding AD and heart diseases have
been focused on association analysis. Many researchers have identified genetic/epigenetics
variants and phenotypes that are significantly associated with disease pathology. While most
of these studies utilize association analysis as the analytical platform, the signals identified by
association studies can only explain a small proportion of the heritability of complex diseases
and a large proportion of risk factors remain undiscovered, which is the limitation of genome-

wide association studies (GWAS). In addition, the biological system usually functions in a
systematic or causal way, thus causation analysis is key to uncover the risk mechanisms of
complex diseases. The relationship between association and causation is that causation can be
used to infer association, but the reverse cannot be guaranteed. Traditionally, the gold standard
for causation analysis is using interventions in randomized controlled trials (RCT). However,
RCT is not feasible for genetics/epigenetics data for either ethical or technical reasons.

The major objective of this research is thus to propose methods to uncover the causal
mechanisms between genetic/epigenetic factors and phenotypes such as environmental and
lifestyle factors for complex diseases. First, I proposed a bivariate causal discovery method to
uncover the pairwise causal relationships between factors. Second, I proposed a network
analysis framework to construct the causal network among genetic/epigenetic variants and
phenotypic factors. Finally, I applied the bivariate causal discovery method and causal network
construction method to the two complex diseases: Alzheimer's disease (AD) and heart failure
(HF) data. Simulations and applications results were discussed in the following sections.
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1. BACKGROUND
1.1 Literature Review
1.1.1 Alzheimer’s Disease

Alzheimer's disease (AD) is an irreversible chronic neurodegenerative disease that causes
problems with memory, thinking, behavior and social skills, and is not a normal part of aging
(Burns and Iliffe 2009). It has been estimated that the number of people with Alzheimer’s
disease will be up to 13.8 million in the United States by the year of 2050 (Alzheimer's &
Dementia 2017). The disease is named after Dr. Alois Alzheimer who noticed changes in the
brain tissue of a woman who had died of an unusual mental illness with symptoms of memory
loss, language problems, and unpredictable behavior in 1906 (Berchtold and Cotman 1998).

AD contributes to 60 to 80 percent of dementia that leads to continuous loss of memory and
other cognitive abilities and worsens over time, which would disrupt a person's ability to
function independently. Experts suggest that more than 5.5 million Americans may have
Alzheimer’s caused dementia with the majority of them being age 65 or older (NIH 2020).
Most commonly, people with Alzheimer’s symptoms first appear in their mid-60s. The early
signs may include forgetting newly learned information, but as disease progresses, there will
be onset of severe memory and cognitive impairment. Typical symptoms may include
disorientation, mood and behavior changes; serious confusions about events, time and place
and suspicions about family and friends; more worsening memory loss and behavior changes.
Patients may also experience difficulty in speaking, swallowing and walking. Ultimately,
1

patients will lose the ability to carry out the simplest daily and cognitive tasks, and even have
to depend completely on others to perform basic activities of daily living (Alzheimer’s
Association 2020). Unfortunately, current treatments for AD symptoms are not able to prevent
or hamper the progression of the disease and no current cure is available.

Many researchers have been studying Alzheimer’s disease and discovered that brain proteins
of AD patients fail to function normally. Researchers also identified several candidate genes
that may be related to the onset of AD. For example, having one form of the apolipoprotein E
(APOE) gene does increase a person’s risk of getting AD (Strittmatter et al. 2019; Mahley and
Huang 2006; Hall et al. 2006). However, the exact cause of the brain proteins damage and
disease has not been fully understood. The cause for most Alzheimer's cases is still mostly
unknown except for 1% to 5% of cases where genetic factors have been identified (Reitz and
Mayeux 2014). Scientists believe that AD is caused by a combination of genetic,
environmental, and lifestyle factors, which is yet to be confirmed. As a result, in this
dissertation, we developed a causal analysis framework to assess the causal relationship
between various types of factors (such as genetic/epigenetic and phenotypic factors) on
Alzheimer’s disease patients, to help understand the mechanism of AD.

1.1.2 Heart Failure

2

Heart failure (HF), also known as congestive heart failure, is a chronic and progressive disease
that the heart muscle is not pumping properly. It usually leads to providing insufficient blood
to meet body’s needs and not enough force to pump blood to the rest of the body, thus the body
gets less oxygen than it needs (Mayo Clinic 2020). Today, about 5.8 million people in the
United States have heart failure, affecting both children and adults, and heart failure is
considered a common condition. Overall, there are around 2% of adults affected by heart
failure and the percentage increases to 6–10% in those over the age of 65. And for those above
75 years old, the rates are greater than 10% (Dickstein et al. 2008; Metra and Teerlink 2017).

Heart failure can be ongoing or occur suddenly. The common signs and symptoms may include
shortness of breath (could be accompanied by coughing), fatigue and weakness of your body
(tiredness), swelling in some of your body (i.e. ankles, feet, legs, abdomen, and veins in the
neck), increased need to urinate at night, etc. If the heart failure is caused by heart attack, there
will also be presence of chest pain. As disease progresses, it is difficult to perform everyday
activities such as walking, climbing stairs, dressing clothes or carrying groceries (National
Clinical Guideline Centre (UK) 2010).

Heart failure is considered as a complex disease which is a result of multifactorial interaction
among genetic predisposition, environmental and lifestyle factors. Common risk factors
include high blood pressure, diabetes, other heart diseases or conditions, tobacco and alcohol
use. HF condition can be further complicated if other diseases co-exist, such as kidney and
liver failure. Genetic predisposition is also a risk factor such as family histories of heart failure
3

(American Heart Association 2020). Unfortunately, similar to Alzheimer’s disease, there is no
current cure to heart failure. Current treatments can improve the signs and symptoms of heart
failure and thus improve the quality of life and the lifespan of patients. Treatments may include
keeping a healthy lifestyle, taking medications and medical procedures and surgeries.

Researchers have also tried to understand the mechanism of heart failure through scientific
research. Exploring the interactions among different types of traits among heart failure patients
could deepen our understanding of disease mechanism and help develop targeted therapies.
However, in genetic and epigenetic studies, most research have focused on association analysis.
Although some risk factors have been identified to be associated with the disease, there is a
need to uncover the causal relationships among multiple risk factors. Through causation studies,
we can further explore the mechanism of heart failure and provide instructions for clinical
treatments. For example, there has been increasing research recently assessing the influence of
genetic variations on metabolism and other risk factors of heart failure. The dicarboxylic acid
hexadecanedioate (hexadecanedioate) is a metabolite that has been identified to be associated
with blood pressure (Alharbi et al, 2017). Many GWAS studies have discovered several genetic
loci associated with hexadecanedioate, but currently there is limited research focusing on the
causal interactions among genes, hexadecanedioate and blood pressure. This dissertation
developed a causal framework to uncover the causal pathway of genes, hexadecanedioate and
blood pressure.

4

1.1.3 Bivariate Causal Discovery

Genome-wide association analysis (GWAS) has been widely used to test the pairwise
association between genetic variants and phenotypes, dealing with different data types. For
example, the relationship between a discrete variable and a continuous variable; the
relationship between two continuous variables; the relationship between two discrete
variables. But there is no current method uncovering the causal relationships between two
observed variables for human genetics data when randomized controlled experiments are not
feasible. Causation analysis in statistics, refers to the establishment of cause and effect
(Rohlfing and Schneider 2018), or in other words, regards the problem of drawing
conclusions about whether some entity we can observe influences another entity (Kurthen
and Enßlin 2020). In probability setting, suppose that 𝑋 and 𝑌 are two random variables with
joint distribution 𝑃(𝑋, 𝑌). If an external intervention that is from outside the system under
consideration forces the variable 𝑋 to have the value 𝑥 and keeps the rest of the system
unchanged, after 𝑌 is measured, the resulting distribution of 𝑌, 𝑃(𝑌|𝑑𝑜(𝑥) is defined as the
causal effect of 𝑋 on 𝑌 (Pearl 2012).

As mentioned, GWAS analysis lacks the ability to detect causal relationships between two
variables. To transit from association to causation analysis, researchers proposed several
bivariate causal discovery methods to evaluate the causal relationships between two observed
variables. Additive Noise Model (ANM) (Hoyer et al., 2009), information geometry causality
inference (Daniusis et al., 2010; Janzing et al., 2012) and linear non-Gaussian acyclic model
5

(Shimizu et al., 2006) are methods discussed in past literature and assume different
assumptions. In this dissertation, the additive noise models (ANM) was utilized for bivariate
causal discovery (Hoyer et al. 2009) focusing on two continuous variables.

For ANM, there are three major assumptions: 1. no selection bias, 2. no feedback and no
confounding, 3. independence of cause and mechanism (ICM) (Mooij. 2016). ICM means
that the mechanism that generates cause 𝑋 and the mechanism that generates effect 𝑌 from the
cause 𝑋 are independent. In probability setting, this could be expressed as the cause
distribution 𝑃(𝑋) and the conditional distribution 𝑃(𝑌|𝑋) being independent.

The expression of ANM is the following (Mooij. 2016):
𝑌 = 𝑓(𝑋) + 𝑒

In the equation, 𝑌 is a non-linear function of potential cause 𝑋 plus a random error 𝑒, which
can be with any distributions. Alternatively, we could assess potential cause 𝑌 on effect 𝑋:
𝑋 = 𝑓(𝑌) + 𝑒

It is worth noting that only one of the two causal directions could hold for ANM: 𝑋 → 𝑌 or 𝑌 →
𝑋. That is, at most one of the two directions could hold.

6

Under ICM assumption, the principal for inferring causal direction under ANM is then
transformed into testing the independence between the cause and the residual term. The method
for testing independence was introduced in the following section 1.1.4.

1.1.4 Hilbert-Schmidt Independence Criterion

There is a wide range of dependence measures for statistical test of independence, for example,
Pearson and Spearman correlation test. Covariance can be used to measure association between
two variables, but it lacks the ability to test the independence between two variables for all
settings. For example, it does not work when the two variables are not jointly normally
distributed. As a result, kernel-based independence measures have been developed to evaluate
dependencies between variables. Hilbert-Schmidt independence criterion (HSIC) was thus
proposed by researchers to measure the degree of dependence between two variables (Gretton
et al. 2005).

Calculation of the HSIC consists of the following steps (Mooij et al. 2016).
Step 1: Use test dataset to fit the regression model.
𝑦𝑖 = 𝑓̂(𝑥𝑖 ) + 𝐸𝑌 (𝑖), 𝑖 = 1, … , 𝑚. (𝑚 observations)
Step 2: Calculate the residuals from the model obtained above:
𝜀𝑖 = 𝐸𝑌 (𝑖) = 𝑦𝑖 − 𝑓̂(𝑥𝑖 ), = 1, … , 𝑚.
7

Step 3: Select two Gaussian kernel functions k E ( i ,  j ) and k x ( x1 , x2 ) (Gretton et al. 2005).
Calculate the Kernel matrices:

𝐾𝐸𝑌

𝑘𝐸 (𝜀1 , 𝜀1 ) ⋯
⋮
⋮
=[
𝑘𝐸 (𝜀𝑚 , 𝜀1 ) ⋯

𝑘𝐸 (𝜀1 , 𝜀𝑚 )
𝑘𝑥 (𝑥1 , 𝑥1 ) ⋯
⋮
⋮
⋮
], 𝐾𝑥 = [
𝑘𝐸 (𝜀𝑚 , 𝜀𝑚 )
𝑘𝑥 (𝑥𝑚 , 𝑥1 ) ⋯

𝑘𝑥 (𝑥1 , 𝑥𝑚 )
⋮
].
𝑘𝑥 (𝑥𝑚 , 𝑥𝑚 )

Step 4: Calculate HSIC for measuring dependence between residual 𝜀𝑖 and potential cause
variable 𝑋 (Jiao et al. 2018):
1

𝐻𝑆𝐼𝐶 2 (𝐸𝑌 , 𝑋) = 𝑚2 𝑇𝑟(𝐾𝐸𝑌 𝐻𝐾𝑋 𝐻),
1

where 𝐻 = 𝐼 − 𝑚 𝟏𝑚 𝟏𝑇𝑚 , 𝟏𝑚 = [1,1, … ,1]𝑇 and 𝑇𝑟 denotes the trace of the matrix.

1.1.5 Directed Acyclic Graph and Structural Equation Model

Bivariate causal discovery methods such as additive noise models discussed above can be
used to discover the causal relationship between two observed variables, but it lacks the
ability to include additional variables into the analysis. In addition, many past genetic
analysis of quantitative traits have focused on single trait analysis. However, the biological
system is rather complex and multiple traits tend to be correlated. For example, multiple
phenotypes can be correlated and bivariate discovery lacks the ability to leverage the
correlations among different traits. To overcome the limitations of bivariate causal discovery,
8

directed graphical models and structural equation model can be utilized to model the
complex causal structures among phenotypes, genetic and other risk factors.

Directed Acyclic Graph

Directed graphical model is comprised of nodes and edges. The nodes represent the variables
while edges indicate the dependence structures among variables (nodes), and the inter-node
connections have a direction denoted by an arrowhead. Directed acyclic graphs (DAG)
belong to graphical models and are defined as finite directed graphs with no cycle. That is,
it is impossible to start at a node A, travel through edges in the directions of the arrows, and
get back to node A. Variables are represented as nodes in DAGs, with edges between nodes
represented as causal relationships (Xiong 2018). And causal relationship between two
variables in DAGs must be unidirectional, that is, they cannot cause each other. Figure 1
below is an example of DAG.
Figure 1: A DAG Example

Y1
X1

X2

Y2

Y3
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Structural Equation Model

In traditional regression models, the variables on the left side of the equations are dependent
variables, while variables on the right side of the equations are independent (explanatory)
variables. However, sometimes it is difficult to distinguish the two as the dependent
variables in some equations can be independent variables in other equations and the
variables in the equations may affect each other. To accommodate such settings and the
interactions among variables, structural equation model can thus be a powerful tool to
describe such data structure, and infer causal relationships among the variables in the
equations. Structural equation models (SEMs) incorporate causal assumptions as part of the
model and each equation is a representation of causal relationships between a set of variables
(Pearl 2012).

SEMs classify variables into two types: endogenous variables (X) and exogenous variables
(Y). Endogenous variables are variables determined through joint interaction with all the
other variables in the system or out of the system (dependent variables). Exogenous
variables are external variables but affect the value of the endogenous variables (explanatory
variables). In a typical SEM, the system consists of 𝑀 endogenous variables and 𝐾
exogenous variables (𝑚 observations):
M endogenous variables: 𝑌 = [𝑦1 , . . . , 𝑦𝑀 ]
𝐾 exogenous variables: X = [𝑥1 , . . . , 𝑥𝑘 ]
10

Figure 2 below is a graphical representation of SEM, with exogenous variables being the
cause and endogenous variables being the effect.

Figure 2: A SEM Example

The SEMs can be expressed in mathematical format (Xiong 2018):
𝑦1 𝛾1𝑖 + ⋯ + 𝑦𝑀 𝛾𝑀𝑖 + 𝑥1 𝛽1𝑖 + ⋯ + 𝑥𝐾 𝛽𝐾𝑖 + 𝑒𝑖 = 0, 𝑖 = 1, ⋯ , 𝑚

In matrix notation:
𝑌Γ + 𝑋Β + 𝐸 = 0

The 𝛾’s (Γ in matrix notation) and 𝛽’s (Β in matrix notation) are the unknown parameters or
coefficients of the equation system, and E = [𝑒1 , . . . , 𝑒𝑚 ] denotes the random error. 𝛾 ’s
11

indicates the causal directions among endogenous variables while 𝛽’s indicates the causal
directions from 𝑋 to 𝑌. The endogenous variables and exogenous variables are observed
variables, where random error represent all the unmeasured factors and all other unmodeled
causes of the variables. There are several methods of estimating the unknown parameters of
the equations. For example, maximum likelihood method, two-state least squares (2SLS)
method, and three-stage least squares (3SLS) method. Maximum likelihood estimation
method assumes the normal distribution of the endogenous variables (Judge et al. 1980);
however, it is usually unlikely in real world data that such assumption will hold. In addition,
ordinary least square methods for parameter estimations will lead to inconsistent estimators.
2SLS and 3SLS, on the other hand, do not assume distribution of the endogenous and
exogenous variables (Judge et al. 1980; Zellner and Theil 1962). 2SLS is a widely used
single equation method (Judge et al. 1980) while 3SLS fully explores information in the
structural equations and jointly estimate all structural equations (Zellner and Theil 1962). In
this dissertation, 2SLS as a most widely used method was utilized for SEM parameter
estimations.

1.2 Public Health Significance

Alzheimer’s disease and heart failure are two complex diseases affecting millions of people
across the globe. The diseases are caused by the combination of genetic, epigenetic,
environmental and other lifestyle factors, however, the interplay among these factors still
remains a challenge to researchers (Dempfle et al., 2008). Much of the research in
12

genetics/epigenetics studies regarding AD and heart diseases have been focused on association
or correlation analysis. Genetic variants and quantitative traits have been identified to be
significantly associated with disease pathology. Yet, the genetic variants identified from
association studies can only explain a small proportion of the heritability of complex diseases
and a large proportion of risk factors remain undiscovered. In addition, the biological system
usually functions under causal structures, thus association analysis is insufficient to dissect the
risk mechanism of complex diseases. To explore causal inference, randomized controlled trials
(RCT) has been widely accepted as the best framework to uncover the causal relationship
between intervention and effect. However, randomized controlled experiments are sometimes
expensive, unethical and technically infeasible in the field of genetics, especially for human
genetics data. As a result, establishing causal analysis framework will enrich the investigating
tools of understanding complex diseases pathology and facilitating public health research.

The methods proposed in this dissertation provided a modeling framework to discover the
causal relationships between risk factors and disease phenotypes. Both bivariate causal
discovery method and network causal analysis method were discussed, with applications to
two complex diseases: Alzheimer’s disease and heart failure.

1.3 Specific Aims
As discussed above, causal study is still not widely explored for Alzheimer’s disease and heart
failure, and most genetic and epigenetic studies were based on association analysis. In addition,
13

randomized controlled trials are not viable in many observational studies to make causal
inferences. To bridge the gap of causation analysis in the two complex diseases mentioned
above, the major objective of this research was to propose methods to uncover the causal
mechanism for the two diseases. This dissertation proposed methods for both pairwise causal
discovery on continuous variables and network-based causal structure analysis.

Aim 1: To develop bivariate causal discovery method for continuous variables. Additive
noise model was proposed to deal with two continuous variables.

ANM discussed in literature review can be used to deal with causation analysis between two
observed variables. However, with only ANM, there are limitations. There is no closed
analytical forms for the asymptotic null distribution of the HSIC, which makes it difficult to
calculate the p-values of the independence tests between the cause and the residual term. To
overcome the limitations, we proposed adding a permutation test to calculate the p-values
of the causal test statistics.

Aim 2: To develop the causal network-based model to account for more variables into the
analysis. A structural equations model with integer programming (IP) was proposed (SEM
with IP).

Under SEM and DAG, we could have a causal framework to construct the causal network
among variables. However, with pure SEM, there are limitations. SEM could potentially
14

generate a bidirectional relationship between variables, instead of unidirectional, thus
generating cyclic graphs, instead of an acyclic graph. To overcome the limitations, we
proposed adding an extra integer programming step to SEM model.

Aim 3: To apply the ANM and SEM with IP to Alzheimer’s disease data and heart failure
data, with the goal of uncovering the causal mechanisms in terms of genetic and phenotype
information for the two diseases, respectively.

2. METHODS
2.1 Methods for Aim 1

Aim 1: To develop bivariate causal discovery method for continuous variables. Additive
noise model was proposed to deal with two continuous variables.

2.1.1 Statistical Modeling for Additive Noise Model

ANM was utilized as the method to assess bivariate causal relationships between two observed
variables. As discussed in previous sections, ANM adopted the assumptions of no
confounding, no selection bias and no feedback between variables. Consider a bivariate ANM
where 𝑌 (effect) is a nonlinear function of 𝑋 (cause) and independent additive noise 𝐸𝑌 :

15

Y = f Y ( X ) + EY
X ~ PX , EY ~ PEY ,

(1)

where 𝑋 and 𝐸𝑌 are independent. Then, the density 𝑃𝑋,𝑌 is said to be inferred by the additive
noise model from 𝑋 to 𝑌 (Mooij et al. 2016). The alternative ANM between 𝑋 and 𝑌 is 𝑌 →
𝑋:
X = f X (Y ) + E X
Y ~ PY , E X ~ PE X ,

(2)

where 𝑌 and 𝐸𝑋 are independent.

As discussed in previous sections of independence of cause and mechanism, given two random
variables, 𝑋 and 𝑌 which are related causally, 𝑋 → 𝑌 (“ 𝑋 causes 𝑌 ”), then there exists a
fundamental independence between the distribution of the cause 𝑃(𝑋) and the mechanism
which relates the cause 𝑋 to the effect 𝑌. As a result, causation between two variables is
defined as the independence between the distribution of cause and conditional distribution of
the effect, given cause. In ANM, such idea of causal relationship identification is then
transformed into testing the independence between the cause 𝑋 and the residual term 𝐸𝑌 .
However, if there is causal relationship exist between 𝑋 and 𝑌 , only one of the causal
directions could hold. That is, it is either 𝑋 → 𝑌 or 𝑌 → 𝑋, it cannot simultaneously exist, or
the causation is not identified by ANM.

The general procedure for bivariate causal discovery is given as follows (Mooij et al. 2016;
Jiao et al. 2018):
16

Step 1: Divide a dataset into a training dataset Dtrain = {Yn , X n } and a test dataset

~ ~
Dtest = {Ym , X m } .
Step 2: Use 𝐷𝑡𝑟𝑎𝑖𝑛 and implement nonlinear regression methods for both directions (fitting the
models).
(a) Regress Y on X : Y = fY (X)+ EY and
(b) Regress X on Y : X = fX (X)+ EX .
Step 3: Apply the estimated regression model via 𝐷𝑡𝑟𝑎𝑖𝑛 to 𝐷𝑡𝑒𝑠𝑡 to predict residuals:

~
~
(a) EˆYX = Y − fˆY ( X )
~
~
(b) Eˆ X Y = X − fˆX (Y )
2
2
Step 4: Calculate the dependence measures HSIC ( EY , X ) and HSIC ( E X , Y ) .

Step 5: Infer causal direction based on independence tests:
2
2
X → Y if HSIC ( EY , X )  HSIC ( E X , Y ) ;

(4)

2
2
Y → X if HSIC ( EY , X )  HSIC ( E X , Y ) .

(5)

If HSIC2 ( EY , X ) = HSIC2 ( E X ,Y ) , then causal direction is undecided by ANM.

Larger 𝐻𝑆𝐼𝐶 2 indicates stronger dependence between the cause and the residual term, which
is evidence against causal relationships between the potential cause and effect being tested.

However, with the above ANM procedure only, there are limitations when assessing causal
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relationships in practice because there is no closed analytical form for the asymptotic null
distribution of the HSIC. This makes it difficult to calculate the p-values of the independence
tests between the cause and the residual term. To overcome the limitations, we proposed adding
a permutation test to calculate the p-values of the causal test statistics. We defined a causal test
hypothesis and a test statistic:

𝐻0 : no causations 𝑋 → 𝑌 and 𝑌 → 𝑋 (That is, there is no causal relationship exists between the
two variables).
Define a test statistic:
𝑇𝐶 = |𝐻𝑆𝐼𝐶 2 (𝐸𝑌 , 𝑋) − 𝐻𝑆𝐼𝐶 2 (𝐸𝑋 , 𝑌)|.

(6)

The permutation test was performed in the following way. Let’s suppose that the total number
of permutations is 𝑁. For each permutation, 𝑥𝑖 , 𝑖 = 1, … , 𝑚 were fixed and 𝑦𝑖 , 𝑖 = 1, … , 𝑚
were randomly shuffled. Each permutation created a different arrangement of the observed
data points. Then, ANM was fitted to obtain residuals 𝐸𝑋 (𝑖), 𝐸𝑌 (𝑖), 𝑖 = 1, … , 𝑚 and test
statistic 𝑇𝐶 for each permutation and permutation was repeated for 𝑁 times. The goal of
permutation test was to obtain all possible values of the test statistic under all possible
rearrangements of the observed data points. The p-values were defined as the proportions of
the statistic 𝑇̃𝐶 (calculated from the permuted data) greater than or equal to 𝑇̂𝐶 (calculated from
the original data). If there is causal relationship identified by the p-values from permutation
test, then we go to equations (4) and (5) above to infer causal directions. As mentioned
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previously, only one of these two directions could hold. The causal relationship between two
observed variables can then be identified by ANM.

2.1.2 Simulation Settings for Additive Noise Model

The simulation for ANM with permutation test was based on the following way. The data with
100,000 subjects were simulated from the model:
𝑌 = 𝑋2 + 𝑒
where 𝑋~𝑁(0,1) and 𝑒~𝑁(0,0.01).

Then the samples were randomly selected with the size of 500, 1000 and 2000 from the
population to calculate and compare the Type I error rates and powers of the ANM causal tests.
The number of permutations was set to 500 and the significance level was set to 0.05.

2.2 Methods for Aim 2

Aim 2: To develop the causal network-based model to account for more variables into the
analysis. A structural equation model with integer programming was proposed.

2.2.1 Statistical Modeling for Structural Equation Model
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SEMs introduced in previous section 1.1.5 can be utilized as a causal uncovering method to
assess the causal relationships among multiple traits. However, with pure SEM, there are
limitations. SEM could potentially generate a bidirectional relationship between variables,
instead of unidirectional, thus generating cyclic graphs, instead of an acyclic graph. To
overcome the limitations, we proposed adding an extra integer programming step to SEMs.

Integer programming is an optimization problem in which some or all of the variables are
restricted to be integers. In network analysis, multiple nodes are regarded as variables, so a
combination of SEM and optimization problem on multiple variables can be introduced to
causal network analysis. We set 𝑣 as a node, and 𝑊 as the potential parent node, we can
define an indicator variable 𝑥(𝑊 → 𝑣) to be either 0 or 1, to represent the presence and
absence of parent 𝑊, indicating whether a variable should be included as cause. Thus, the
causal directions among variables in SEMs can be restricted to unidirectional. A standard
form of integer linear programming (Xiong 2018) is
min 𝑐 𝑇 𝑋
Subject to 𝐴𝑋 ≤ 𝑏 and 𝑋 ∈ 𝑍 𝑛
where 𝑐 ∈ 𝑅 𝑛 , 𝑏 ∈ 𝑅 𝑚 , 𝐴 ∈ 𝑅 𝑚×𝑛 and 𝑍 = {0,1,2, … }
If all variables are restricted to the values from 𝐵 = {0,1}, we have a 0-1-integer linear
programming:
min 𝑐 𝑇 𝑋
Subject to 𝐴𝑋 ≤ 𝑏 and 𝑋 ∈ 𝐵 𝑛
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where 𝑐 ∈ 𝑅 𝑛 , 𝑏 ∈ 𝑅 𝑚 , 𝐴 ∈ 𝑅 𝑚×𝑛 and 𝐵 = {0,1}

SEM with IP for identifying DAG is then transformed into a score-based optimization problem
for parameter and structure estimation (Jaakkola et al. 2002). We can define a DAG as 𝐺 =
(𝑉, 𝐸) where 𝑉 represents the nodes and 𝐸 represents edges. The set of causal variables of 𝒗 ∈
𝑉 defined as 𝐶𝑣 , and the DAG can be denoted by the causal variables sets 𝐶 = {𝐶1 , 𝐶2 , … , 𝐶𝑝 }.
To construct a DAG 𝐷 is to select the optimal score of the summation of score functions
(objective function): 𝑆(𝐷) =∑𝑣∈𝑉 𝑆(𝑣, 𝐶𝑣 ). Then the score-based optimization problem is to
search for a DAG that minimizes the global score 𝑆(𝐷) over all possible DAGs, i.e.
min ∑𝑣∈𝑉,𝐶𝑣∈𝐷 𝑆(𝑣, 𝐶𝑣 ), where global score is the summation of the score of each node, subject
𝐷

to the integer 0-1 constraint (Xiong 2018):

𝑝

𝐽𝑣

min ∑ ∑ 𝐶(𝑣, 𝑊𝑗𝑣 )𝑥(𝑊𝑗𝑣 → 𝑣)
𝑣=1 𝑗𝑣
𝐽𝑣

𝑐𝑜𝑛𝑠𝑡𝑟𝑎𝑖𝑛𝑡𝑠: ∑ 𝑥(𝑊𝑗𝑣 → 𝑣) = 1,

𝑣 = 1, … , 𝑝

𝑗𝑣 =1

∀𝐶 ⊆ V: ∑

∑
𝑣∈𝐶

𝑤𝑗 |𝑤𝑗 ∩𝐶|<𝑘,𝑗𝑣 =1,…,𝑗𝑣
𝑣

𝑥(𝑊𝑗𝑣 → 𝑣) ≥ 𝑘, ∀𝑘, 1 ≤ 𝑘 ≤ |𝐶|

𝑣

𝑥(𝑊𝑗𝑣 → 𝑣) = 0 𝑜𝑟 1
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𝑣 represents a specific node 𝑣 , and 𝑊𝑗𝑣 refers to one of the possible parent set of 𝑣 .
𝐶(𝑣, 𝑊𝑗𝑣 ) denotes the linear score function for the pair of node 𝑣 and its parent set 𝑊𝑗𝑣 .
𝑥(𝑊𝑗𝑣 → 𝑣) = 1 if and only if 𝑊𝑗𝑣 is the parent set for the node 𝑣.

Learning a DAG is then to identify the DAG with optimal score by searching all possible
DAGs that are represented by the sets of parent variables. For each candidate DAG, it has a
score measuring how well DAG fits the data. The task is to search for a DAG that optimizes
the score via integer programming by searching all possible DAGs represented by the sets of
parent variables. Take Figure 3 as an example, it showed all possible directed acyclic graph
with three nodes. The task is to search for the best one with the optimal score via SEM with
IP.

Figure 3: SEM with IP for DAG Learning Example
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With SEM plus integer programming to identify the optimal DAG, a causal analysis
framework was created to discover the causal structures among multiple different variables
and traits to potentially model the causal network.
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2.2.2 Simulation Settings for Structural Equation Model

The simulations were based on DNA methylation data. Two settings were set up. First, a 10nodes scenario was set up, with 6 nodes (endogenous variables) and 4 outside nodes
(exogenous variables). 4 CpG sites (exogenous variables 𝑋) were randomly selected from
DNA methylation in Alzheimer’s disease neuroimaging initiative (ADNI) datasets. The
endogenous variables 𝑌 nodes were generated by:
𝑌=𝐴𝑋+𝑒,
where A~𝑈𝑛𝑖𝑓(1, 2), 𝑒~𝑁(0, 0.01)

Then resampling was used to generate the simulated data of the sample size of 100, 300, 500
and 1000, respectively. Second, the 20-nodes scenario was set up with 16 nodes
(endogenous variables) and 4 outside nodes (exogenous variables). The procedure was
similar to the 10-nodes scenario, except that 16 endogenous variables were created. To
compare the performance for SEM with and without integer programming, simulations for
both methods were conducted under the two data scenarios.

The DAGs with 10 nodes and 20 nodes were randomly generated as the ground truth. Both
DAGs and the network data mentioned above were randomly generated for 1,000 times.
Then we implemented SEM model for causal discoveries for the simulated data, and
compared them with ground truth to evaluate performances. The two metrics for
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comparisons were type 1 error and power of detection (PD). 𝑁𝑡 was defined to be the total
number of edges existed among 1,000 networks in the randomly generated DAGs, 𝑁𝑜 be the
total number of edges that did not appear in these 1,000 networks, 𝑁𝑇𝑟𝑢𝑒 be the total number
of true edges discovered by the SEM algorithm for the simulated data, and 𝑁𝐹𝑎𝑙𝑠𝑒 be the
false edges detected among 𝑁𝑜 . Then the type 1 error rate was defined as
PD was defined as

𝑁𝑇𝑟𝑢𝑒
𝑁𝑡

𝑁𝐹𝑎𝑙𝑠𝑒
𝑁𝑜

and power

. These metrics were compared between SEM with and without

integer programming, respectively.

2.3 Methods for Aim 3
Aim 3: To apply the ANM and SEM with IP to Alzheimer’s disease data and heart failure
data, with the goal of uncovering the causal mechanism in terms of genetic and phenotypic
information for the two diseases, respectively.

2.3.1 Alzheimer’s Disease Data

Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a multi-study that aims to improve
clinical trials for the prevention and treatment of Alzheimer’s disease, which contains clinical,
imaging, genetic, epigenetic, biomarkers information. Recently, there has been much research
studying how epigenetic might affect the AD pathology, especially with DNA methylation.
DNA methylation is a heritable epigenetic marker including the covalent transfer of a methyl
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group that is added to DNA molecule (Jin et al. 2011). There have been studies indicating that
DNA methylation is associated with AD pathology and demonstrate the potential to impact the
AD phenotypes in these subjects (Yokoyama et al. 2017). However, past research for DNA
methylation in aging and the development of Alzheimer‘s disease were focused on association
analysis (GWAS), while lacking the causal framework to dissect the causal mechanism
between DNA methylation and AD phenotypes. Our study is thus would like to utilize ANM
and SEM as the causal framework to uncover how the DNA methylation affect the phenotypes
and disease status of AD patients. Genome-wide causation analysis for DNA methylation on
AD patients using ANM was first used to identify methylated genes that had pairwise causal
effect on phenotypes of AD patients across three time points: baseline, 12 months, and 24
months. Then, we can examine the progression of these causal relationships across time points.

The dataset utilized is DNA methylation and phenotypes data in ADNI dataset, with 647
subjects. There are 866,836 CpG sites for DNA methylation and 15 phenotypes after datapreprocessing. Because of the relatively large number of CpG sites in DNA methylation and it
is quite unstable and complex to put all the CpG sites into the SEM model and the
computational cost could be quite expensive, bivariate ANM model as a genome-wide
causation method was first used to filter and identify some candidate CpG sites (mapped to
genes) and help us narrow down the target genes for later SEM analysis. And the p value cutoff
for inferring causation is set to p value < 10−6 because of the computational cost of ANM and
the number of permutation time was set to 106 . The equation below is the expression of ANM,
where 𝑌 is the effect, and 𝑋 is the cause. In our study, CpG sites were treated as cause and
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phenotypes were treated as effect. Thus, the hypothesis being tested was whether certain CpG
sites have a pairwise causal relationship with each phenotypes.
𝑌 = 𝑓(𝑋) + 𝑒

The pairwise causation analysis under ANM model was conducted between DNA methylation
with 866,836 CpG sites and six memory and cognitive variables which are critical risk factors
for AD: episodic memory, working memory, semantic memory, cognitive score, perceptive
orientation, MMSE.

After identifying causal genes by ANM, to better demonstrate the causal network structure
among different phenotypic factors and the causal genes of AD, SEM with IP and DAG were
also utilized to construct the network. There were 15 phenotypes analyzed in SEM model:
a). Cognitive function traits: cognitive score, perceptual orientation, perceptual speed, working
memory, episodic memory, semantic memory and MMSE (mini mental state exam)
b). Lipoprotein metabolism traits: cholesterol level (CHL), BMI, weight, diastolic blood
pressure (DBP), systolic blood pressure (SBP), (SBP and DBP shared the same causal edges
in our causal framework, so they were combined into one node “BP” for demonstration
purpose in DAGs)
c). Other factors: functional activity (FAQ), age and disease status (AD)
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In our analysis, phenotypic factors and disease status were considered as endogenous variables
(𝑌) and the candidate causal genes were considered as exogenous variables (𝑋) in SEM model.

2.3.2 Heart Failure Data

Atherosclerosis Risk in Communities study (ARIC) is a prospective epidemiologic study
conducted in four U.S. communities, with the goal of investigating the causes of
atherosclerosis and its clinical outcomes, as well as variations in cardiovascular risk factors.

This study utilized ANM and SEM with IP as tools to help uncover the causal pathway of
genes – hexadecanedioate – blood pressure. The dataset for this study is ARIC, containing
genotypes SNPs dosage data, phenotypic risk factors and hexadecanedioate metabolite. The
dataset was divided into two sets: African Americans (1638 subjects), and European
Americans (1428 subjects). There were 26,434,100 SNPs in African Americans and
22,487,821 SNPs in European Americans to be analyzed. The following analysis was
conducted for the two race groups separately. GWAS analysis was first conducted to filter
SNPs that showed associations with hexadecanedioate (p value < 10−5 ). Then, pairwise
causation analysis was conducted on the identified SNPs above using ANM to further discover
SNPs that demonstrated causations with hexadecanedioate (because of the computational time
limitation of permutation test in ANM, p value < 10−5 was set to infer causation). In our study
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of ANM, SNPs were treated as cause and hexadecanedioate was treated as effect. Thus, the
hypothesis being tested was whether certain SNPs have a pairwise causal relationship with
hexadecanedioate levels. After filtering causal SNPs by pairwise ANM, minor allele frequency
(MAF) cutoff of 5%, as well as linkage disequilibrium (LD) checking were also performed on
the identified SNPs (mapped to genes).

After obtaining several candidate causal genes that had causal effect on hexadecanedioate for
the two race groups respectively from ANM, we incorporated them in to the SEM with IP
model to further test for causal pathway. SEM as discussed in previous chapters, can
accommodate more variables into the analysis and their interactions, which is different from
the bivariate ANM. To better model genes – hexadecanedioate – blood pressure causal
pathway, SEM with IP was utilized and more phenotypic factors were introduced into the
model. The factors included: age, BMI, CHL, SBP, DBP, glucose level, prevalence of coronary
heart disease (CHD), prevalence of hypertension (HTN), hypertension drug usage and
prevalence of diabetes. In our analysis, hexadecanedioate and other phenotypic factors were
considered as endogenous variables (𝑌) and the candidate genes were considered as
exogenous variables (𝑋) in SEM model. Since SBP and DBP shared common causal directions
and relationships in our analysis, they were combined into one node (blood pressure) for
demonstration purpose in DAGs.

29

2.4 Declaration on Human Subjects

This dissertation research has a focus on statistical methods development on causal discovery
on human genetic data when interventions in randomized controlled trials for causal inference
is not feasible. The dataset utilized were Alzheimer’s Disease Neuroimaging Initiative (ADNI)
and Atherosclerosis Risk in Communities study (ARIC). The information used in the dataset
included DNA methylation and phenotypes data in ADNI dataset, and genotype SNPs data,
phenotypes and metabolite data in ARIC dataset. All data were pre-existing and de-identified.
The IRB approval for the use of dataset in my dissertation research was obtained by my
dissertation advisor, Dr. Momiao Xiong, under UTHealth IRB approval (HSC-SPH-18-0819).

3. RESULTS
3.1 Results for Aim 1

The simulation results for ANM with permutation test were shown in Table 1 with the number
of permutations being 500 times, and the significance level accessing being 0.05 level.

Table 1 Power and Type1 error rate for ANM.

Nsample

500

Power
1000

2000

0.6245

0.7433

0.8006

500

Type 1 error
1000

2000

0.032

0.044

0.05

30

From Table 1, we could observe that the powers varied a lot among different sample sizes.
With a sample size of 500, ANM could only achieve 62% of power. However, when the sample
size increased to 2000, the power could reach 80%. This may suggest that ANM could
potentially not work well in detecting causations when the sample sizes were below 500. Type
1 error rates, on the other hand, were generally controlled at 0.05 significance level with slight
inflation when the sample size reached 2000. However, it is also worth noting that the number
of permutations was set to 500 times mainly because of the high computational cost of
permutation test, especially with large sample sizes. Higher number of permutations and lower
nominal significance level are worth exploring in future work to further validate the model
performance in terms of power and type 1 error rate.

3.2 Results for Aim 2

The simulation results for SEM with IP in identifying the optimal DAG and causal structure
were shown in Table 2 and Table 3.

Table 2: Power and Type1 error rate for SEM with and without integer programming (10
nodes)
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6 Nodes (endogenous variables) + 4 additional outside nodes (exogenous variables)

Nsample
SEM+
Integer
programming
Only SEM

100

Power
300
500

1000

100

Type1 error
300
500

1000

0.6483

0.6844

0.7549

0.8117

0.1695

0.1477

0.1286

0.0908

0.3835

0.4102

0.4522

0.4753

0.3537

0.2735

0.2507

0.2288

Table 3: Power and Type1 error rate for SEM with and without integer programming (20
nodes)
16 Nodes (endogenous variables) + 4 additional outside nodes (exogenous variables)

Nsample
SEM+
Integer
programming
Only SEM

100

Power
300
500

1000

100

Type1 error
300
500

1000

0.6190

0.6553

0.7032

0.7603

0.1913

0.1710

0.1495

0.1143

0.3225

0.3597

0.3985

0.4376

0.3108

0.2982

0.2691

0.2501

Table 2 and Table 3 showed that SEM with integer programming performed significantly better
than SEM only in terms of powers and type 1 error rates for both 10 nodes and 20 nodes
scenarios. This result indicated that SEM plus the integer programming demonstrated better
ability to detect causations among variables than SEM only. In addition, 10 nodes scenario
showed better performance than 20 nodes scenario, indicating that the number of nodes may
affect the ability for SEM to detect causations. Thus, it should be cautious when considering
the number of nodes included in SEM models. Also, as sample sizes increased, the SEM
method demonstrated greater ability to achieve better power and better controlled type 1 error
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rate. Similar to ANM, the SEM with IP had expensive computational cost, especially when the
number of parent nodes were high. Sometimes there maybe a trade-off between the
computational time and the number of parent nodes considered, thus affecting the model
performances.

3.3 Results for Aim 3
3.3.1 Application of ANM and SEM with IP to Alzheimer’s Disease

The tables (Table 4 to Table 9) below listed the genes that had pairwise causal relationships to
the six memory and cognitive variables.

Table 4: List of Candidate Genes with significant causations with Semantic Memory at
three time points.

Baseline
TARDBP
CHCHD10

12 months
MAPT
PSEN1
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24 months
PSEN1
APP
MRI1
KPNA6

Table 5: List of Candidate Genes with significant causations with Working Memory at
three time points.

Baseline
SYCE2
TUBBP1
FGF4
FOLR2

12 months
MAPT
ZNF497
DPF2
PSEN1
KPNA6

24 months
KPNA6
APP
CTB-5E10.3
PLCL2
SPTLC1P1
SDHAF2
DSG2
MRI1

Table 6: List of Candidate Genes with significant causations with Episodic Memory at
three time points.

Baseline
EIF3G
NOL3
MCRS1

12 months
LAMTOR1
MPST
GRN
KCNH3
CCT6B

24 months
MAPT
KLHL6
A1BG
LAMTOR1
GRN
CD33
APP

Table 7: List of Candidate Genes with significant causations with Perceptive Orientation
at three time points.

Baseline
ADAM24P
VPRBP

12 months
GABBR1
ANKRD52
MYOZ1
HMGB1P25
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24 months
TARDBP
SFRP2
C9ORF72
INPP5D

Table 8: List of Candidate Genes with significant causations with Cognitive Score at three
time points.

Baseline
ZNF740
KRT19P6
ZFPL1
C19ORF53

12m
FLT1P1
SNORA49
KNOP1P4
OR2L8

24m
C9ORF72
FLT1P1
NUMA1
CHMP2B

Table 9: List of Candidate Genes with significant causations with MMSE at three time
points.

Baseline
TPM3P2
CHMP2B
XPC

12m
TUBA4A
MRPL40
CD33
C9ORF72

24m
CHMP2B
ATF4P3
CD33
NXF1
APP

We can see from Table 4 to Table 9 that that there were increasing number of genes (CpG sites)
identified to be causal to the memory and cognitive traits above for AD patients as time
progressed. And the causal genes discovered at early time point were quite different from those
discovered at later point. We can also observe that at early points, the causal genes identified
varied a lot for these memory and cognitive traits, however, we started to see some common
causal genes for the different traits such as gene APP, PSEN1, MAPT and C9ORF72 at later
time points. For example, gene APP, PSEN1 and MAPT demonstrated causations with episodic
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memory, working memory and semantic memory at later time points. And these genes are
confirmed in past literature that have critical causation relationships to the AD pathology.

Since SEM plus integer programming cannot handle large number of nodes quite well and to
better demonstrate the causal network, we only included the common causal genes that showed
causations with several memory and cognitive traits at 12 months and 24 months by ANM:
gene APP, PSEN1, MAPT and C9ORF72. At early time points (baseline), however, we
included all the causal genes identified by ANM to the SEM model to further validate the
causations since the number of nodes are smaller at baseline.
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Figure 4: Genes – Phenotypes Network at Baseline
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Figure 5: Genes – Phenotypes Network at 12 months
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Figure 6: Genes – Phenotypes Network at 24 months
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In Figure 4 to Figure 6 above at three different time points, we observed the causal relationships
among genes, phenotypes and AD disease status. From the phenotypic standpoint, it was
evident that as disease progressed, more and more phenotypes, especially memory and
cognitive traits were causally related to Alzheimer’s disease (the red dotted lines in the figures).
Working memory and episodic memory were discovered to be causally related to AD across
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the three time points, while semantic memory, MMSE and cognitive score demonstrated causal
relations with AD at later time points. Genes were also identified under SEM and integer
programing method to have causal relationships with various traits. Gene PSEN1 demonstrated
causal relationships with semantic and working memory at 12 months and 24 months,
suggesting that gene PSEN1 may be a genetic factor that influence the later stage of AD. And
based on literature, gene PSEN1 are responsible for familial AD (Fenoglio et al. 2020). It is
also worth noting that gene APP demonstrated causations with semantic, working and episodic
memory at 24 months time point. And gene APP is also known as amyloid precursor protein
(Lill and Bertram 2011), which is in the pathway of amyloid processing and plays a causal role
in AD pathology (Lanoiselee et al. 2017). Gene CD33 showed causations with MMSE at both
12 months and 24 months time points. Gene C9ORF72 was discovered to be causal to cognitive
impairment and perceptual orientation at 24 months time points, and it has been discussed in
literature that gene C9ORF72 repeat expansion is the most common cause of frontotemporal
dementia (FTD) (Fenoglio et al. 2020). Lipoprotein metabolism traits such as CHL, BMI,
weight and blood pressure did not seem to causally interact with the cognitive and memory
traits for these subjects, nor the disease status. Based on the findings discussed above, the
epigenetic effect of DNA methylation on the progression of Alzheimer’s disease was a
dynamic process. The genes that demonstrated causal pathway in AD were quite different
between early and late time points. As time progressed, the genetic variants tended to have
more interactions with the biological system and disease mechanism.
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3.3.2 Application of ANM and SEM with IP to Heart Failure

The results for identifying pairwise causal (SNPs) with hexadecanedioate by ANM were the
following: for African American group, 164 SNPs were identified to be associated with
hexadecanedioate, and 12 of these SNPs showed strong causal relationships to
hexadecanedioate; for European American group, on the other hand, 154 SNPs showed
association with hexadecanedioate while 17 of them demonstrated causations. Table 10 to
Table 11 below listed the SNPs (mapped to genes) that showed both association and causation
with hexadecanedioate for the two race groups.

Table 10: P-values of SNPs that showed both significant associations and causations with
hexadecanedioate for African Americans

RS Number
rs1439612183
rs556278150
rs4149056
rs533352484
rs188163008
rs573822091
rs550647571
rs2136582
rs2136581
rs805741
rs805725
rs1276545015

Chr
chr8
chr8
chr12
chr17
chr17
chr17
chr17
chr20
chr20
chr20
chr20
chr21

Position
7896243
12285396
21178615
20011521
20032631
20102001
20201747
5711111
5711116
5711493
5713480
6144634

Gene

DEFB4A
SLCO1B1
SPECC1
SPECC1
SPECC1
SPECC1
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P values
Causation Association
<E-05
5.42E-11
<E-05
2.69E-06
<E-05
2.63E-06
<E-05
7.79E-11
<E-05
3.81E-12
<E-05
3.50E-12
<E-05
5.01E-10
<E-05
1.36E-06
<E-05
1.36E-06
<E-05
1.06E-06
<E-05
5.09E-06
<E-05
2.64E-06

Table 11: P-values of SNPs that showed both significant associations and causations with
hexadecanedioate for European Americans

RS Number
rs143987388
rs141778506
rs149378705
rs570603161
rs367595907
rs141369986
rs4149056
rs144705402
rs775545390
rs182744734
rs867598991
rs111330505
rs77446883
rs773417326
rs1374594991

Chr
chr7
chr7
chr7
chr7
chr7
chr12
chr12
chr13
chr16
chr16
chr16
chr17
chr17
chr19
chr21

Position
410515
438554
442192
702849
839818
1282768
21178615
18692976
1062396
1152890
1153217
1636474
1692215
718853
5131154

Gene

LOC116435278
PRKAR1B
SUN1
ERC1
SLCO1B1

CACNA1H
CACNA1H
SCARF1
PALM
LOC102724159

P values
Causation Association
<E-05
9.59E-06
<E-05
2.19E-08
<E-05
2.08E-08
<E-05
2.70E-06
<E-05
5.54E-06
<E-05
4.25E-06
<E-05
1.08E-09
<E-05
7.52E-06
<E-05
1.51E-10
<E-05
6.59E-06
<E-05
6.58E-06
<E-05
8.90E-09
<E-05
3.59E-08
<E-05
9.21E-08
<E-05
1.74E-08

Minor allele frequency (MAF) cutoff of 5% were then applied for the SNPs identified above
for the two race groups, respectively, and the results were shown in Table 12 and Table 13:
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Table 12: P-values of SNPs that showed both significant associations and causations with
hexadecanedioate with a 5% MAF cutoff for African Americans
RS Number
rs11685543
rs556278150
rs4149056
rs2136582
rs2136581
rs805741
rs805725

Chr
chr2
chr8
chr12
chr20
chr20
chr20
chr20

P value
Causation Association
<E-05
2.89E-09
<E-05
2.69E-06
SLCO1B1 <E-05
2.63E-06
<E-05
1.36E-06
<E-05
1.36E-06
<E-05
1.06E-06
<E-05
5.09E-06

Pos
11466521
12285396
21178615
5711111
5711116
5711493
5713480

Gene

MAF
0.2
0.071
0.066
0.298
0.298
0.297
0.315

Table 13: P-values of SNPs that showed both significant associations and causations with
hexadecanedioate with a 5% MAF cutoff for European Americans
RS Number
rs141369986
rs4149056
rs111330505

Chr
chr12
chr12
chr17

Pos
1282768
21178615
1636474

Gene

ERC1
SLCO1B1
SCARF1

P value
Causation Association
<E-05
4.25E-06
<E-05
1.08E-09
<E-05
8.90E-09

MAF
0.05
0.16
0.05

For SNPs in Table 12 and Table 13, the linkage disequilibrium (LD) were also checked among
them, and the results showed that the four SNPs on chromosome 20 in Table 12 for African
American group were highly correlated and were in high LD (𝑅 2 values close to 1). As a result,
we could only retain one of these four SNPs in the following analysis. Table 14 and Table 15
below were the SNPs included in the SEM model for further analysis (four for African
Americans and three for European Americans):
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Table 14: SNPs identified to have causations with hexadecanedioate for African
Americans after checking LD
RS Number
rs11685543
rs556278150
rs4149056
rs2136582

Chr
chr2
chr8
chr12
chr20

Pos
11466521
12285396
21178615
5711111

Gene

SLCO1B1

Table 15: SNPs identified to have causations with hexadecanedioate for European
Americans after checking LD
RS Number
rs141369986
rs4149056
rs111330505

Chr
chr12
chr12
chr17

Pos
1282768
21178615
1636474

Gene

ERC1
SLCO1B1
SCARF1

Based on the results above from ANM in Table 14 and Table 15, we obtained several candidate
genes that have causal effect on hexadecanedioate for the two race groups respectively, to be
further tested for causal pathway. It is worth noting that SNP rs4149056 (chr12, position
21178615), mapped to gene SLCO1B1 (labeled in red in above tables), has been discussed in
literature that demonstrated association with hexadecanedioate for the TwinsUK and KORA
cohorts (Mennie et al. 2017). SEM with IP was next utilized to better model genes –
hexadecanedioate – blood pressure causal pathway. To better demonstrate the analysis
incorporating other phenotypic factors, directed acyclic graphs (DAGs) identified by SEM
with IP were drawn to represent the causal network among these factors.
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Figure 7 and Figure 8 demonstrated the causal network constructed incorporating candidate
causal genes, phenotypic and the metabolite (hexa):

Figure 7: Causal Network for African American Group

SLCO1B1
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Figure 8: Causal Network for European American Group

SLCO1B1 SCARF1

SEM with IP was conducted for both race groups, and Figure 7 and Figure 8 indicated that
gene SLCO1B1 (rs4149056 on chromosome 12) had causal effect on both hexadecanedioate
and blood pressure (SBP and DBP) for African American group. The SNP rs4149056 encodes
the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein in the biological system,
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and this protein is found primarily in the liver which regulates the uptake of numerous drugs
and natural compounds (SNPedia, 2020).

For European American group, on the other hand, gene SLCO1B1 (rs4149056 on chromosome
12) and gene SCARF1 (rs111330505 on chromosome 17) were identified to have causal effect
on both hexadecanedioate and blood pressure (SBP and DBP). SNP rs111330505 encodes the
protein which is a scavenger receptor that is expressed in endothelial cells. It regulates the
uptake of chemically modified low density lipoproteins, including acetylated low-density
lipoprotein (Ac-LDL), and it may be involved in atherogenesis (NCBI, 2020). And for both
race groups, hexadecanedioate was discovered to have causal relationships on blood pressure
(SBP and DBP).

Causal pathways for gene- hexadecanedioate-blood pressure were discovered by ANM and
SEM with IP methods. ANM was first utilized as a feature selection tool to identify candidate
genes that showed causal effect on hexadecanedioate. Then SEM with IP was implemented
incorporating the identified candidate genes and other phenotypic factors to model a more
complex causal network. The analysis was conducted for two race groups separately. Gene
SLCO1B1 was identified to have causal effects on both hexadecanedioate and blood pressure
for African American group, and gene SLCO1B1 and gene SCARF1 were observed in the same
way for European American group. Hexadecanedioate was discovered to have causal
relationships on blood pressure for both race groups.
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There has been several GWAS studies assessing the pathway of genes, hexadecanedioate and
blood pressure under association framework. However, there is limited research uncovering
causal relationships for the three factors mentioned above. Using ANM and SEM with IP, gene
SLCO1B1 (on chromosome 12), which was previously identified to be associated with
hexadecanedioate and blood pressure (Menni et al. 2015, 2017; Yu et al. 2016), was discovered
to have causal effect on both hexadecanedioate and blood pressure for both African and
European Americans. And the causal effect of hexadecanedioate on blood pressure was
discovered by our network causal discovery framework. In addition, novel discoveries of gene
SCARF1 (on chromosome 17) for European American group was identified to have causal
effects on both hexadecanedioate and blood pressure. Our findings provided more insights for
unraveling the causal pathway of gene- hexadecanedioate-blood pressure. We discovered a
few genetic loci that could potentially be causal to hexadecanedioate and further affect blood
pressure, in addition to the current GWAS association analysis framework. And our results
could provide more information that worth further investigation in future research.

4. DISCUSSIONS AND CONCLUSIONS

4.1 Discussions and Conclusions

The goal of this dissertation research was to propose methods for causal discovery in
genetic/epigenetic studies when randomized controlled experiment is infeasible. In past
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literature, the major framework to uncover genetic variants that play critical roles in disease
pathology such as Alzheimer’s disease and heart failure is association analysis. GWAS study
has been widely employed to study complex diseases. However, the signals uncovered by
association analysis can only discover a small proportion of variants and may omit critical
signals. Thus, the transition from association framework to causal framework could facilitate
the research in bioinformatics in understanding disease mechanisms. Mainly for ethical and
technical reasons, traditional gold standard for causal inference which is interventions in
randomized controlled trials is not feasible for human genetics data. As a result, we proposed
two methods in this dissertation to handle causal discovery in genetic analysis of AD and HF.

The first method proposed is a bivariate causal discovery method called ANM for
continuous variables. ANM could discover the causal relationships between two observed
variables, where effect is modeled as a non-linear function of cause, plus a random error.
However, with only ANM, it is impossible to get the closed analytical forms for the
asymptotic null distribution of the HSIC, which makes it difficult to calculate the p-values
of the independence tests between the cause and the residual term. To overcome the
limitations, we proposed adding a permutation test to calculate the p-values of the causal
test statistics. The simulation results indicated that ANM performed well in terms of
controlling type 1 error rates to reasonable level, and the power could reach 80% as sample
size increase to 2000. However, the number of permutation test was set to 500 in our
simulation setting because of the computational cost, higher number of permutations may
worth exploring to better validate the model performance in the future. It is also worth
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exploring the lower nominal significance level (such as 0.01) to better control type 1 error
rate for the model.

In addition to bivariate causal discovery, we also proposed network causal discovery method
to accommodate more variables into the analyses and accounted for the correlations among
different types of variants. SEM is a causal method used to describe the causal relations among
endogenous and exogenous variables. However, with SEM only, it could potentially generate
a bidirectional relationship between variables, instead of unidirectional, thus generating cyclic
graphs, instead of an acyclic graph. To overcome the limitations, we proposed adding an extra
integer programming step to SEM model, transforming DAG learning to an optimization
problem and searching for the best DAG and causal structure for the variables. We combined
DAG and SEM plus integer programming as the network causal discovery method to model
complex causal structures. The simulation for 10 nodes and 20 nodes cases indicated this
combined method had better ability to detect causations among variables than SEM only.
However, SEM with IP also demonstrated expensive computational cost, especially when the
numbers of parent node were set to higher numbers. As a result, there is sometimes a trade-off
between computational time and better model performance.

In summary, we could first utilize ANM as a feature selection tool to help us identify and
screen some candidate causal genetic loci from the large number of genetic variants. Then we
could use SEM plus integer programming method to model the interactions among candidate
causal variants and other factors (i.e. phenotypes) to describe more complex causal networks.
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To see if this ANM+SEM and integer programming causal analysis framework works well in
real world data, we applied this framework to AD (ADNI) and HF (ARIC) data, respectively.

For Alzheimer’s disease, we discovered several DNA methylations (CpG sites mapped to
genes) that played causal role in disease pathology. For example, gene APP and PSEN1 were
identified by our framework to be causal to several memory and cognitive traits for AD
subjects, and both of these genes were confirmed in literature. In addition to the causal genes
we discovered that could be confirmed by literature, novel causal genes especially at early time
points of AD were also uncovered, which provided clues for future clinical and biological
researchers to validate the results.

For heart failure, we uncovered the causal pathway of genes – hexadecanedioate – blood
pressure. Previous research showed several SNPs (mapped to genes) were associated with
hexadecanedioate metabolite, and hexadecanedioate were associated with BP. In our analysis,
we discovered that gene SLCO1B1 (on chromosome 12), which was previously identified to
be associated with hexadecanedioate and blood pressure (Menni et al. 2015, 2017; Yu et al.
2016), showed causal effect on both hexadecanedioate and blood pressure for both African and
European Americans. We also found out that hexadecanedioate was causal to blood pressure
for ARIC dataset.
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4.2 Future Works

First, for Aim 3 heart failure ARIC application study, additional analysis may worth exploring.
Since a 5% cutoff of MAF on SNPs were applied, we only focused on common SNPs for both
race groups, while lacking the ability to accommodate rare variants into the analysis. In
addition, the power to detect statistically significant rare variant associations and causations
decrease as the MAFs decrease, so there is a need to find methods to accommodate such
situation. One possible solution could be grouping rare variants together at the level of gene.
We could explore functional principal component analysis (FPCA) (Xiong 2018) to summarize
genetic variations within genes. FPCA is widely used for GWAS with next-generation
sequencing data (Luo et al. 2011) and hence can also be applied to causation studies between
two variables. Functional principal component (FPC) is an extension of principal component
and can be used as summary statistics. FPCs can utilize genetic information of the individual
variants as well as correlation information (LD) among variants. The FPCs summarizes genetic
variation across the genomic region as a function of its genomic location, and employs intrinsic
functional dependence structure of the data and all available genetic information of the variants
in the genomic region (Wang et al. 2016). Specifically, we could summarize individual SNPs
into continuous functional principal component scores and collectively use rare variant
information. We could then use these continuous FPC scores as the variables for both bivariate
discovery ANM and network discovery SEM for causal analysis.

52

Second, for bivariate ANM, we only focused on handling two continuous variables while not
studying the causal relationships between two discrete variables, or one continuous and one
discrete variable. Since genetic data usually takes on various data types, it would be helpful to
explore different data types under ANM method. In two continuous ANM, the independence
test between cause and the residual term is HSIC. However, for two discrete variables case,
other test method such as chi-square test may be employed and worth exploring.

Third, for SEM with integer programming, we only focused on small number of nodes scenario
mainly because of the expensive computational cost of integer programming. However, the
biological system is rather complex and sometimes the interactions can be quite complicated
among large number of variables. Future work could be to increase the number of nodes and
vary the ratios of endogenous variables and exogenous variables to further assess the stability
of SEM with integer programming. In addition, the SEM with IP we proposed took linear
relationships among variables, however, it is also worth exploring the non-linear form of the
relationships in the future. For example, nonlinear SEMs including complex ANMs can also
be used to discover causal networks. Also, the SEM with IP we proposed is a cross-sectional
method, future work may include incorporating time factor into the analysis.

53

REFERENCES
Alharbi NH., McBride MW., Padmanabhan S., Graham D., (2017) Abstract P223: The ωoxidation Pathway Underlies Hexadecanedioate Induced Blood Pressure Elevation.
Hypertension.2017;70:AP223.
https://www.ahajournals.org/doi/10.1161/hyp.70.suppl_1.p223
Alzheimer's disease facts and figures. Alzheimer's & Dementia. 2017;13(4):325-73. doi:
https://doi.org/10.1016/j.jalz.2017.02.001.
Amy S. Yokoyama, John C. Rutledge and Valentina Medici (2017) DNA methylation
alterations in Alzheimer’s disease. Environmental Epigenetics, 2017, 1–11. doi:
10.1093/eep/dvx008
American Heart Association (2020). What is Heart Failure? https://www.heart.org/en/healthtopics/heart-failure/what-is-heart-failure Retrieved on April 7, 2020.
Ashrafian H, Darzi A, Athanasiou T (2015) A novel modification of the Turing test for
artificial intelligence and robotics in healthcare. Int J Med Robot 11: 38-43.
Bergen SE, O’Dushlaine CT, Ripke S, et al (2012) Genome-wide association study in a
Swedish population yields support for greater CNV and MHC involvement in schizophrenia
compared with bipolar disorder. Mol Psychiatry 17:880–886. doi: 10.1038/mp.2012.73
Berchtold NC, Cotman CW (1998). "Evolution in the conceptualization of dementia and
Alzheimer's disease: Greco-Roman period to the 1960s". Neurobiology of Aging. 19 (3): 173–
89. doi:10.1016/S0197-4580(98)00052-9.
Besserve, M., Shajarisales, N., Schölkopf, B., Janzing, D. (2017) Group invariance principles
for causal generative models. arXiv preprint arXiv:1705.02212.
Bilian Jin, Yajun Li, and Keith D. Robertson. (2011) DNA Methylation: Superior or
Subordinate in the Epigenetic Hierarchy? Genes & Cancer. 2(6) 607–617 DOI:
10.1177/1947601910393957
Budhathoki, K., and Vreeken, J. (2017) Causal inference by stochastic complexity.
arXiv:1702.06776.
Bui AL, Horwich TB, Fonarow GC (2011). "Epidemiology and risk profile of heart failure".
Nature Reviews. Cardiology. 8 (1): 30–41. doi:10.1038/nrcardio.2010.165
54

Burns A, Iliffe S. (2009). "Alzheimer's disease". BMJ. 338: b158. doi:10.1136/bmj.b158.
Daniusis P., Janzing D., Mooij J., Zscheischler J., Steudel B., Zhang K., and Schlkopf. B.
(2010) Inferring deterministic causal relations. In Proceedings of UAI, pages 143–150, 2010.
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et
al. (2008). "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure
2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure
Association of the ESC (HFA) and endorsed by the European Society of Intensive Care
Medicine
(ESICM)".
European
Heart
Journal.
29
(19):
2388–442.
doi:10.1093/eurheartj/ehn309
Fisher , R. A. (1918) The correlation between relatives on the supposition of Mendelian
inheritance. Proc. Roy. Soc. Edinburgh. 52, 99-433.
Glymour, C. (2015) The causal revolution, observational science and big data. Lecture
presented at Ohio University in the History and Philosophy of Science series, Athens, Ohio.
Gretton, A., Bousquet, O., Smola, A., and Schölkopf B. (2005) Measuring statistical
dependence with Hilbert–Schmidt norms. In Proceedings of the International Conference on
Algorithmic Learning Theory, 63–77.
Grunwald, P. D., & Vitanyi, P. M. B. (2004) Shannon Information and Kolmogorov
complexity. IEEE Trans. Information Theory, arXiv:cs/0410002.
Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R,
Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H (January 2006). "Cholesterol, APOE
genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba". Neurology. 66
(2): 223–27. doi:10.1212/01.wnl.0000194507.39504.17. PMC 2860622. PMID 16434658
Health Information. Mayo Clinic. 2020.
Hoyer, P. O., Janzing, D., Mooij, J. M., Peters, J., & Schölkopf, B. (2009) Nonlinear causal
discovery with additive noise models. Advances in neural information processing systems.
689-696.
Janzing, D., Schölkopf, B. (2010) Causal Inference Using the Algorithmic Markov Condition
IEEE Transactions on Information Theory, 56(10):5168-5194.
Janzing D., Mooij J., Zhang K., Lemeire J., Zscheischler J., Daniusis P., Steudel B., and
Scholkopf B. (2012) Information-geometric approach to inferring causal directions. Artificial
Intelligence.
55

Kurthen, M., Enßlin, T. (2020) A Bayesian Model for Bivariate Causal Inference. arXiv
preprint https://arxiv.org/pdf/1812.09895.pdf.
Lanoiselee HM, Nicolas G, Wallon D, Rovelet-Lecrux ´A, Lacour M, Rousseau S, Richard
AC, Pasquier F, Rollin-Sillaire A, Martinaud O, Quillard-Muraine M, dela Sayette V,
Boutoleau-Bretonniere C, Etcharry-Bouyx F, Chauvire V, Sarazin M, le Ber I, Epelbaum S,
Jon- ´veaux T, Rouaud O, Ceccaldi M, Felician O, Godefroy O, ´Formaglio M, Croisile B,
Auriacombe S, Chamard L, Vincent JL, Sauvee M, Marelli-Tosi C, Gabelle A, Ozsancak ´C,
Pariente J, Paquet C, Hannequin D, Campion D, collaborators of the CNR-MAJ project (2017)
APP, PSEN1,and PSEN2 mutations in early-onset Alzheimer disease:A genetic screening
study of familial and sporadic cases. PLoS Med 14, e1002270.
Le, T., Hoang, T., Li, J., Liu, L., Liu, H. & Hu, S. (2016) A fast PC algorithm for high
dimensional causal discovery with multi-core PCs. IEEE/ACM Transactions on
Computational Biology and Bioinformatics. doi:10.1109/TCBB.2016.2591526.
Lemeire J and Janzing D. (2013) Replacing causal faithfulness with algorithmic independence
of conditionals. Minds and Machines. 23(2):227–249.
Lill CM, Bertram L (2011) Towards unveiling the genetics of neurodegenerative diseases.
Semin Neurol 31, 531-541
Liu, F. and Chan, L. (2016) Causal inference on discrete data via estimating distance
correlations. Neur. Comp., vol. 28, no. 5, pp. 801–814.
Luo, L., Boerwinkle, E., & Xiong, M. (2011). Association studies for next-generation
sequencing. Genome research, 21(7), 1099–1108. https://doi.org/10.1101/gr.115998.110
Mahley RW, Weisgraber KH, Huang Y (April 2006). "Apolipoprotein E4: a causative factor
and therapeutic target in neuropathology, including Alzheimer's disease". Proceedings of the
National Academy of Sciences of the United States of America. 103 (15): 5644 – 51.
Bibcode:2006PNAS..103.5644M. doi:10.1073/pnas.0600549103.
Menni C., et al. (2015) Metabolomic Identification of a Novel Pathway of Blood Pressure
Regulation Involving Hexadecanedioate. Hypertension. 2015; 66:422–429.
https://doi.org/10.1161/HYPERTENSIONAHA.115.05544
Menni C, Metrustry SJ, Ehret G, Dominiczak AF, Chowienczyk P, Spector TD, et al. (2017)
Molecular pathways associated with blood pressure and hexadecanedioate levels. PLoS ONE
12(4): e0175479. https://doi.org/10.1371/journal.pone.0175479

56

National Clinical Guideline Centre (UK) (August 2010). "Chronic heart failure: National
clinical guideline for diagnosis and management in primary and secondary care: Partial
update". National Clinical Guideline Centre: 19–24. PMID 22741186
National
Institute
on
Aging
(2020.
Alzheimer's
Disease
Fact
Sheet.
https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet Retrieved on Feb. 7, 2020.
NCBI. National Center for Biotechnology Information.
https://www.ncbi.nlm.nih.gov/snp/advanced. Retrieved June 20, 2020.
Metra M, Teerlink JR (October 2017). "Heart failure". Lancet. 390 (10106): 1981–1995.
doi:10.1016/S0140-6736(17)31071-1
Mooij, J.M., Peters, J., Janzing, D., Zscheischler, J., & Schölkopf, B. (2016) Distinguishing
Cause from Effect Using Observational Data: Methods and Benchmarks. Journal of Machine
Learning Research. 17, 32:1-32:102.
Nowzohour, C. and Bühlmann, P. (2016) Score-based causal learning in additive noise models.
Statistics. 50, 471-485.
Parascandolo, G., Rojas-Carulla, M., Kilbertus, N., Schölkopf, B. (2017) Learning
Independent Causal Mechanisms. arXiv preprint arXiv:1712.00961.
Pearl, J. (2010a). An introduction to causal inference. The International Journal of Biostatistics
6 DOI: 10.2202/1557–4679.1203
Pearl, J. (2018) Theoretical impediments to machine learning with seven sparks from the causal
revolution. arXiv preprint arXiv:1801.04016.
Peters, J., Bühlman, P. (2014) Identifiability of Gaussian Structural Equation Models with
Equal Error Variances. Biometrika. 101, 219-228.
Peters, J., Janzing, D., Schölkopf, B. (2017) Elements of Causal Inference - Foundations and
Learning Algorithms Adaptive Computation and Machine Learning Series. Cambridge, MA:
The MIT Press.
Peters J, Mooij J, Janzing D, Schoelkopf B. (2011) Identifiability of Causal Graphs using
Functional Models. In Proceedings of the 27th Annual Conference on Uncertainty in Artificial
Intelligence (UAI).
Peters, J., Mooij, J. M., Janzing, D., & Schölkopf, B. (2014) Causal discovery with continuous
additive noise models. The Journal of Machine Learning Research. 15, 2009-2053.
57

Rasmussen, C. E. and Williams, C. K. I. (2006) Gaussian Processes for Machine Learning.
MIT Press.
Reitz C, Mayeux R (2014). "Alzheimer disease: epidemiology, diagnostic criteria, risk factors
and biomarkers". Biochemical Pharmacology. 88 (4): 640–51. doi:10.1016/j.bcp.2013.12.024.
Rohlfing, Ingo; Schneider, Carsten Q. (2018). A Unifying Framework for Causal Analysis in
Set-Theoretic Multimethod Research. Sociological Methods & Research. 47 (1): 37–63.
doi:10.1177/0049124115626170 doi:10.1093/nsr/nwx137.
Jiao, R., Lin, N., Hu, Z., Bennett, D. A., Jin, L., & Xiong, M. (2018). Bivariate Causal
Discovery and Its Applications to Gene Expression and Imaging Data Analysis. Frontiers in
genetics, 9, 347. https://doi.org/10.3389/fgene.2018.00347
Judge. G.G.. W.E. Griftiths. R.C. Hill, and T.C. Lee. (1980) The theory and practice of
econometrics. John Wiley Kr Sons, Inc., New York. 8 10 pp.
Schölkopf, B. and Janzing, D. and Peters, J. and Sgouritsa, E. and Zhang, K. and Mooij, J.
(2012) On Causal and Anticausal Learning. Proceedings of the 29th International Conference
on Machine Learning. 1255-1262.
Shajarisales, N., Janzing, D., Schölkopf, B., Besserve, M. (2015) Telling cause from effect in
deterministic linear dynamical systems. Proceedings of the 32nd International Conference on
Machine Learning. 37, 285–294.
Shi J, Levinson DF, Duan J, et al (2009) Common variants on chromosome 6p22.1 are
associated with schizophrenia. Nature 460:753–757. doi: 10.1038/nature08192
Shimizu, S., Hoyer, P. O., Hyv¨arinen, A., & Kerminen, A. (2006) A linear non-gaussian
acyclic model for causal discovery. Journal of Machine Learning Research. 7, 2003-2030.
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS,
Roses AD (March 1993). "Apolipoprotein E: high-avidity binding to beta-amyloid and
increased frequency of type 4 allele in late-onset familial Alzheimer disease". Proceedings of
the National Academy of Sciences of the United States of America. 90 (5): 1977–81.
Bibcode:1993PNAS...90.1977S. doi:10.1073/pnas.90.5.1977.
Stroup TS, McEvoy JP, Swartz MS, et al (2003) The National Institute of Mental Health
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia
trial design and protocol development. Schizophr Bull 29:15–31
Székely,G.J., Rizzo, M.L., Bakirov,N.K. (2007) Measuring and testing independence by
correlation of distances. Annals of Statistics 35(6), 2769–2794.
58

Székely,G.J., Rizzo, M.L. (2009) Brownian distance covariance. Annals of Applied Statistics
3(4),1236–1265.
SNPedia: a wiki supporting personal genome annotation, interpretation and analysis. Michael
Cariaso; Greg Lennon. Nucleic Acids Research 2011; doi: 10.1093/nar/gkr798
Tereshchenko LG., et al. (2018) Genome‐Wide Associations of Global Electrical
Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and
CHS (Cardiovascular Health Study). Journal of the American Heart Association.
https://doi.org/10.1161/JAHA.117.008160
Timpson, N. J., Greenwood, C. M. T., Soranzo, N., Lawson, D.J., Richards, J. B. (2017)
Genetic architecture: the shape of the genetic contribution to human traits and disease. Nat Rev
Genet. 19, 110-124. doi: 10.1038/nrg.2017.101.
Wang, P. M., Rahman, L., Jin, and M., Xiong, (2016) A new statistical framework for genetic
pleiotropic analysis of high dimensional phenotype data. BMC Genomics 17: 881.
Xiong MM. (2018). Big data in omics and image: integrated analysis and causal inference.
CRC Press.
Yu B., et al. (2016) Loss-of-function variants influence the human serum metabolome.
Science Advances. Vol. 2, no. 8, e1600800. https://doi.org/ 10.1126/sciadv.1600800
Zhang, K., Hyvärinen, A. (2009) On the identifiability of the post-nonlinear causal model. In
Proceedings of the 25th Annual Conference on Uncertainty in Artificial Intelligence (UAI).
Zhang, K., Schölkopf, B., Spirtes, P., Glymour, C. (2018) Learning causality and causalityrelated learning. National Science Review. 5. 26-29. doi:10.1093/nsr/nwx137.
Zellner, Arnold; Theil, Henri (1962). Three-stage least squares: simultaneous estimation of
simultaneous equations. Econometrica. 30 (1): 54–78. doi:10.2307/1911287.

59

